|
Re: Hepalink purchase of Scientific Protein Labs 2014
|
2
|
Resverlogix Corp.
|
May 28, 2015 01:25PM
|
|
Re: Resverlogix Announces Lifting by TSX of Review
|
2
|
Resverlogix Corp.
|
May 11, 2018 03:48PM
|
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 09, 2019 08:08AM
|
|
Re: share value/little perspective
|
2
|
Resverlogix Corp.
|
Sep 03, 2021 11:40AM
|
|
Re: Evacetrapib fails
|
2
|
Resverlogix Corp.
|
May 18, 2017 10:35AM
|
|
Re: 96 hours
|
2
|
Resverlogix Corp.
|
Aug 22, 2017 07:55PM
|
|
Re: Wonderful
|
2
|
Resverlogix Corp.
|
Aug 28, 2017 11:58AM
|
|
Inflammation as a target
|
2
|
Resverlogix Corp.
|
Aug 31, 2017 10:50AM
|
|
Next Hurdle
|
2
|
Resverlogix Corp.
|
Jan 05, 2018 11:12AM
|
|
Re: Grand Cayman
|
2
|
Resverlogix Corp.
|
Jan 01, 2023 12:08PM
|
|
Re: Lilly to Discontinue Development of Evacetrapib
|
2
|
Resverlogix Corp.
|
Nov 17, 2015 10:30AM
|
|
Re: Upcoming RVX presentations, human blood microarray & babbling on FACET analysis
|
2
|
Resverlogix Corp.
|
Jul 24, 2015 05:38PM
|
|
Re: What Jardiance/EMPA-REG Outcome means for RVX-208
|
2
|
Resverlogix Corp.
|
Sep 18, 2015 11:27AM
|
|
Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)
|
3
|
Resverlogix Corp.
|
Jun 15, 2016 11:31AM
|
|
Re: ... unfinished business
|
3
|
Zenith Epigenetics
|
Oct 31, 2018 02:39PM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
3
|
Resverlogix Corp.
|
Sep 09, 2019 06:04PM
|
|
Re: From the floor at AGM
|
3
|
Resverlogix Corp.
|
Sep 13, 2018 12:22PM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
3
|
Resverlogix Corp.
|
Sep 09, 2019 06:24PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
3
|
Zenith Epigenetics
|
Jul 26, 2019 02:59PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
3
|
Zenith Epigenetics
|
Jul 26, 2019 03:07PM
|
